Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
18601
18602
18603
18604
18605
18606
18607
18608
18609
18610
18611
18612
18613
18614
18615
18616
18617
18618
18619
18620
18621
18622
18623
18624
18625
18626
18627
18628
18629
18630
18631
18632
18633
18634
18635
18636
18637
18638
18639
18640
18641
18642
18643
18644
18645
18646
18647
18648
18649
18650
18651
18652
18653
18654
18655
18656
18657
18658
18659
18660
18661
18662
18663
18664
18665
18666
18667
18668
18669
18670
18671
18672
18673
18674
18675
18676
18677
18678
18679
18680
18681
18682
18683
18684
18685
18686
18687
18688
18689
18690
18691
18692
18693
18694
18695
18696
18697
18698
18699
18700
18701
18702
18703
18704
18705
18706
18707
18708
18709
18710
18711
18712
18713
18714
18715
18716
18717
18718
18719
18720
18721
18722
18723
18724
18725
18726
18727
18728
18729
18730
18731
18732
18733
18734
18735
18736
18737
18738
18739
18740
18741
18742
18743
18744
18745
18746
18747
18748
18749
18750
18751
18752
18753
18754
18755
18756
18757
18758
18759
18760
18761
18762
18763
18764
18765
18766
18767
18768
18769
18770
18771
18772
18773
18774
18775
18776
18777
18778
18779
18780
18781
18782
18783
18784
18785
18786
18787
18788
18789
18790
18791
18792
18793
18794
18795
18796
18797
18798
18799
18800
| UnnamedSample_HQ_transcript/96351|m.22145 | UnnamedSample_HQ_transcript/96351 | Coverage 0.938 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 216 | 261 | 0.0059 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/96351|m.22145 | UnnamedSample_HQ_transcript/96351 | Coverage 0.938 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 34 | 79 | 0.099 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/96351|m.22145 | UnnamedSample_HQ_transcript/96351 | Coverage 0.938 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 154 | 200 | 0.024 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/88491|m.21017 | UnnamedSample_HQ_transcript/88491 | Coverage 0.964 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 277 | 322 | 0.0055 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/88491|m.21017 | UnnamedSample_HQ_transcript/88491 | Coverage 0.964 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 216 | 261 | 0.0059 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/88491|m.21017 | UnnamedSample_HQ_transcript/88491 | Coverage 0.964 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 34 | 79 | 0.099 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/88491|m.21017 | UnnamedSample_HQ_transcript/88491 | Coverage 0.964 too low. | 3fc7d26bc797adfa00ce11548597de37 | 323 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 154 | 200 | 0.024 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/62025|m.16454 | UnnamedSample_HQ_transcript/62025 | Coverage 0.990 too low. | d273fe82121fa036ca165fae5ce27182 | 474 | Pfam | PF00232 | Glycosyl hydrolase family 1 | 3 | 464 | 7.6E-142 | T | 22-09-2020 | IPR001360 | Glycoside hydrolase family 1 |
| UnnamedSample_HQ_transcript/68837|m.17732 | UnnamedSample_HQ_transcript/68837 | Coverage 0.989 too low. | d273fe82121fa036ca165fae5ce27182 | 474 | Pfam | PF00232 | Glycosyl hydrolase family 1 | 3 | 464 | 7.6E-142 | T | 22-09-2020 | IPR001360 | Glycoside hydrolase family 1 |
| UnnamedSample_HQ_transcript/16960|m.5993 | UnnamedSample_HQ_transcript/16960 | Coverage 0.266 too low. | 60e7297878427212011fc9cfe0eca217 | 248 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 61 | 112 | 1.9E-12 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/74251|m.18692 | UnnamedSample_HQ_transcript/74251 | Coverage 0.168 too low. | 0a0363fa583db26d6158d7cecd49fa70 | 308 | Pfam | PF00046 | Homeodomain | 254 | 308 | 2.8E-20 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/12771|m.4747 | UnnamedSample_HQ_transcript/12771 | Identity 0.876 too low. | 15659d68418ef0f936b835cfd519f3fa | 871 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 574 | 870 | 3.8E-59 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/12771|m.4747 | UnnamedSample_HQ_transcript/12771 | Identity 0.876 too low. | 15659d68418ef0f936b835cfd519f3fa | 871 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 471 | 528 | 1.3E-22 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/40158|m.11875 | UnnamedSample_HQ_transcript/40158 | Coverage 0.132 too low. | e85bcdef58ec8de716d53652b7de4c67 | 471 | Pfam | PF05199 | GMC oxidoreductase | 309 | 449 | 4.8E-38 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/40158|m.11875 | UnnamedSample_HQ_transcript/40158 | Coverage 0.132 too low. | e85bcdef58ec8de716d53652b7de4c67 | 471 | Pfam | PF00732 | GMC oxidoreductase | 4 | 215 | 1.0E-56 | T | 22-09-2020 | IPR000172 | Glucose-methanol-choline oxidoreductase, N-terminal |
| UnnamedSample_HQ_transcript/45534|m.13042 | UnnamedSample_HQ_transcript/45534 | Coverage 0.982 too low. | e85bcdef58ec8de716d53652b7de4c67 | 471 | Pfam | PF05199 | GMC oxidoreductase | 309 | 449 | 4.8E-38 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/45534|m.13042 | UnnamedSample_HQ_transcript/45534 | Coverage 0.982 too low. | e85bcdef58ec8de716d53652b7de4c67 | 471 | Pfam | PF00732 | GMC oxidoreductase | 4 | 215 | 1.0E-56 | T | 22-09-2020 | IPR000172 | Glucose-methanol-choline oxidoreductase, N-terminal |
| UnnamedSample_HQ_transcript/46061|m.13156 | UnnamedSample_HQ_transcript/46061 | Coverage 0.045 too low. | e85bcdef58ec8de716d53652b7de4c67 | 471 | Pfam | PF05199 | GMC oxidoreductase | 309 | 449 | 4.8E-38 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/46061|m.13156 | UnnamedSample_HQ_transcript/46061 | Coverage 0.045 too low. | e85bcdef58ec8de716d53652b7de4c67 | 471 | Pfam | PF00732 | GMC oxidoreductase | 4 | 215 | 1.0E-56 | T | 22-09-2020 | IPR000172 | Glucose-methanol-choline oxidoreductase, N-terminal |
| UnnamedSample_HQ_transcript/51902|m.14431 | UnnamedSample_HQ_transcript/51902 | Coverage 0.918 too low. | 4ca7b6e9e612127b07b4cf2c3c6bd704 | 535 | Pfam | PF05195 | Aminopeptidase P, N-terminal domain | 67 | 182 | 3.4E-22 | T | 22-09-2020 | IPR007865 | Aminopeptidase P, N-terminal |
| UnnamedSample_HQ_transcript/51902|m.14431 | UnnamedSample_HQ_transcript/51902 | Coverage 0.918 too low. | 4ca7b6e9e612127b07b4cf2c3c6bd704 | 535 | Pfam | PF00557 | Metallopeptidase family M24 | 237 | 503 | 3.4E-55 | T | 22-09-2020 | IPR000994 | Peptidase M24 |
| UnnamedSample_HQ_transcript/62296|m.16505 | UnnamedSample_HQ_transcript/62296 | Coverage 0.909 too low. | 4ca7b6e9e612127b07b4cf2c3c6bd704 | 535 | Pfam | PF05195 | Aminopeptidase P, N-terminal domain | 67 | 182 | 3.4E-22 | T | 22-09-2020 | IPR007865 | Aminopeptidase P, N-terminal |
| UnnamedSample_HQ_transcript/62296|m.16505 | UnnamedSample_HQ_transcript/62296 | Coverage 0.909 too low. | 4ca7b6e9e612127b07b4cf2c3c6bd704 | 535 | Pfam | PF00557 | Metallopeptidase family M24 | 237 | 503 | 3.4E-55 | T | 22-09-2020 | IPR000994 | Peptidase M24 |
| UnnamedSample_HQ_transcript/70452|m.18006 | UnnamedSample_HQ_transcript/70452 | Coverage 0.931 too low. | 7823e74bfc95cd229c0350253c56254e | 330 | Pfam | PF00069 | Protein kinase domain | 37 | 322 | 5.4E-70 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/59238|m.15898 | UnnamedSample_HQ_transcript/59238 | Coverage 0.973 too low. | ee63c59ba29681847171c1a3ba099275 | 209 | Pfam | PF13639 | Ring finger domain | 165 | 204 | 3.3E-9 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/116861|m.24568 | UnnamedSample_HQ_transcript/116861 | Coverage 0.989 too low. | 25563c31450d4cffdec27ac8e9fa1fce | 240 | Pfam | PF00271 | Helicase conserved C-terminal domain | 3 | 27 | 3.0E-5 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/17133|m.6049 | UnnamedSample_HQ_transcript/17133 | Coverage 0.801 too low. | 7b5ceea9c18056582d08022638523fc1 | 1068 | Pfam | PF12455 | Dynein associated protein | 544 | 826 | 6.0E-77 | T | 22-09-2020 | IPR022157 | Dynein associated protein |
| UnnamedSample_HQ_transcript/17133|m.6049 | UnnamedSample_HQ_transcript/17133 | Coverage 0.801 too low. | 7b5ceea9c18056582d08022638523fc1 | 1068 | Pfam | PF01302 | CAP-Gly domain | 6 | 70 | 2.5E-23 | T | 22-09-2020 | IPR000938 | CAP Gly-rich domain |
| UnnamedSample_HQ_transcript/2257|m.1157 | UnnamedSample_HQ_transcript/2257 | Identity 0.901 too low. | da28f85d8a944f72f662e358c58dc2df | 1417 | Pfam | PF11502 | B-cell lymphoma 9 protein | 441 | 477 | 5.5E-6 | T | 22-09-2020 | IPR024670 | B-cell lymphoma 9, beta-catenin binding domain |
| UnnamedSample_HQ_transcript/16399|m.5829 | UnnamedSample_HQ_transcript/16399 | Coverage 0.956 too low. | 88b8561e23a6e603766c63e1ee8be5ae | 375 | Pfam | PF02210 | Laminin G domain | 267 | 351 | 2.0E-12 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/40311|m.11912 | UnnamedSample_HQ_transcript/40311 | Coverage 0.384 too low. | fc83e75525b455c011408f8978f1a2c9 | 232 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 84 | 215 | 1.5E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/25822|m.8426 | UnnamedSample_HQ_transcript/25822 | Coverage 0.327 too low. | fc83e75525b455c011408f8978f1a2c9 | 232 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 84 | 215 | 1.5E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/35213|m.10761 | UnnamedSample_HQ_transcript/35213 | Coverage 0.353 too low. | fc83e75525b455c011408f8978f1a2c9 | 232 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 84 | 215 | 1.5E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/87741|m.20897 | UnnamedSample_HQ_transcript/87741 | Coverage 0.673 too low. | fc83e75525b455c011408f8978f1a2c9 | 232 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 84 | 215 | 1.5E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/99997|m.22629 | UnnamedSample_HQ_transcript/99997 | Coverage 0.595 too low. | fc83e75525b455c011408f8978f1a2c9 | 232 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 84 | 215 | 1.5E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/55730|m.15181 | UnnamedSample_HQ_transcript/55730 | Coverage 0.454 too low. | fc83e75525b455c011408f8978f1a2c9 | 232 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 84 | 215 | 1.5E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/84077|m.20351 | UnnamedSample_HQ_transcript/84077 | Coverage 0.628 too low. | fc83e75525b455c011408f8978f1a2c9 | 232 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 84 | 215 | 1.5E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/93838|m.21788 | UnnamedSample_HQ_transcript/93838 | Coverage 0.644 too low. | fc83e75525b455c011408f8978f1a2c9 | 232 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 84 | 215 | 1.5E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/14900|m.5376 | UnnamedSample_HQ_transcript/14900 | Coverage 0.040 too low. | a12cffcd03e130f045bc87b89c917ab9 | 852 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 157 | 762 | 4.7E-63 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/12776|m.4748 | UnnamedSample_HQ_transcript/12776 | Coverage 0.034 too low. | a12cffcd03e130f045bc87b89c917ab9 | 852 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 157 | 762 | 4.7E-63 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/13358|m.4911 | UnnamedSample_HQ_transcript/13358 | Coverage 0.067 too low. | a12cffcd03e130f045bc87b89c917ab9 | 852 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 157 | 762 | 4.7E-63 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/104937|m.23223 | UnnamedSample_HQ_transcript/104937 | Identity 0.945 too low. | feb31d393f425c6f494467aba2f9a06f | 216 | Pfam | PF14605 | Nup53/35/40-type RNA recognition motif | 31 | 81 | 8.3E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/56509|m.15343 | UnnamedSample_HQ_transcript/56509 | Coverage 0.140 too low. | e76da536b1b3d15ee810c8abc8df85e5 | 607 | Pfam | PF00372 | Hemocyanin, copper containing domain | 24 | 263 | 7.1E-56 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/56509|m.15343 | UnnamedSample_HQ_transcript/56509 | Coverage 0.140 too low. | e76da536b1b3d15ee810c8abc8df85e5 | 607 | Pfam | PF03723 | Hemocyanin, ig-like domain | 273 | 539 | 3.1E-63 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/7018|m.2866 | UnnamedSample_HQ_transcript/7018 | Coverage 0.180 too low. | 6fd09017e0d71115e7b1d5e5ba520ee5 | 1354 | Pfam | PF06009 | Laminin Domain II | 266 | 388 | 1.9E-9 | T | 22-09-2020 | IPR010307 | Laminin domain II |
| UnnamedSample_HQ_transcript/7018|m.2866 | UnnamedSample_HQ_transcript/7018 | Coverage 0.180 too low. | 6fd09017e0d71115e7b1d5e5ba520ee5 | 1354 | Pfam | PF02210 | Laminin G domain | 813 | 932 | 3.2E-12 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/7018|m.2866 | UnnamedSample_HQ_transcript/7018 | Coverage 0.180 too low. | 6fd09017e0d71115e7b1d5e5ba520ee5 | 1354 | Pfam | PF02210 | Laminin G domain | 1029 | 1155 | 7.6E-23 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/7018|m.2866 | UnnamedSample_HQ_transcript/7018 | Coverage 0.180 too low. | 6fd09017e0d71115e7b1d5e5ba520ee5 | 1354 | Pfam | PF02210 | Laminin G domain | 1206 | 1333 | 5.1E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/7018|m.2866 | UnnamedSample_HQ_transcript/7018 | Coverage 0.180 too low. | 6fd09017e0d71115e7b1d5e5ba520ee5 | 1354 | Pfam | PF02210 | Laminin G domain | 632 | 753 | 3.2E-21 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/7018|m.2866 | UnnamedSample_HQ_transcript/7018 | Coverage 0.180 too low. | 6fd09017e0d71115e7b1d5e5ba520ee5 | 1354 | Pfam | PF02210 | Laminin G domain | 402 | 564 | 7.0E-15 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/51134|m.14272 | UnnamedSample_HQ_transcript/51134 | Unmapped. | 9c653f63bfc1c51b9b45e93256c57b54 | 659 | Pfam | PF08762 | CRPV capsid protein like | 361 | 571 | 2.0E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/36883|m.11138 | UnnamedSample_HQ_transcript/36883 | Coverage 0.688 too low. | 7a939b757d8ac50c75dbc12472918d64 | 506 | Pfam | PF07993 | Male sterility protein | 18 | 288 | 4.8E-65 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/36883|m.11138 | UnnamedSample_HQ_transcript/36883 | Coverage 0.688 too low. | 7a939b757d8ac50c75dbc12472918d64 | 506 | Pfam | PF03015 | Male sterility protein | 361 | 454 | 6.3E-23 | T | 22-09-2020 | IPR033640 | Fatty acyl-CoA reductase, C-terminal |
| UnnamedSample_HQ_transcript/6623|m.2748 | UnnamedSample_HQ_transcript/6623 | Coverage 0.107 too low. | 07b2b0d29f4b10e9c112d3d56bb9ffe3 | 717 | Pfam | PF12448 | Kinesin associated protein | 312 | 456 | 3.5E-20 | T | 22-09-2020 | IPR022154 | Trafficking kinesin-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/6623|m.2748 | UnnamedSample_HQ_transcript/6623 | Coverage 0.107 too low. | 07b2b0d29f4b10e9c112d3d56bb9ffe3 | 717 | Pfam | PF04849 | HAP1 N-terminal conserved region | 1 | 237 | 8.1E-66 | T | 22-09-2020 | IPR006933 | HAP1, N-terminal |
| UnnamedSample_HQ_transcript/7108|m.2895 | UnnamedSample_HQ_transcript/7108 | Coverage 0.101 too low. | 07b2b0d29f4b10e9c112d3d56bb9ffe3 | 717 | Pfam | PF12448 | Kinesin associated protein | 312 | 456 | 3.5E-20 | T | 22-09-2020 | IPR022154 | Trafficking kinesin-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/7108|m.2895 | UnnamedSample_HQ_transcript/7108 | Coverage 0.101 too low. | 07b2b0d29f4b10e9c112d3d56bb9ffe3 | 717 | Pfam | PF04849 | HAP1 N-terminal conserved region | 1 | 237 | 8.1E-66 | T | 22-09-2020 | IPR006933 | HAP1, N-terminal |
| UnnamedSample_HQ_transcript/4428|m.1967 | UnnamedSample_HQ_transcript/4428 | Coverage 0.090 too low. | 07b2b0d29f4b10e9c112d3d56bb9ffe3 | 717 | Pfam | PF12448 | Kinesin associated protein | 312 | 456 | 3.5E-20 | T | 22-09-2020 | IPR022154 | Trafficking kinesin-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/4428|m.1967 | UnnamedSample_HQ_transcript/4428 | Coverage 0.090 too low. | 07b2b0d29f4b10e9c112d3d56bb9ffe3 | 717 | Pfam | PF04849 | HAP1 N-terminal conserved region | 1 | 237 | 8.1E-66 | T | 22-09-2020 | IPR006933 | HAP1, N-terminal |
| UnnamedSample_HQ_transcript/22226|m.7491 | UnnamedSample_HQ_transcript/22226 | Coverage 0.831 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF09279 | Phosphoinositide-specific phospholipase C, efhand-like | 212 | 308 | 6.1E-11 | T | 22-09-2020 | IPR015359 | Phosphoinositide-specific phospholipase C, EF-hand-like domain |
| UnnamedSample_HQ_transcript/22226|m.7491 | UnnamedSample_HQ_transcript/22226 | Coverage 0.831 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF00388 | Phosphatidylinositol-specific phospholipase C, X domain | 319 | 466 | 6.5E-60 | T | 22-09-2020 | IPR000909 | Phosphatidylinositol-specific phospholipase C, X domain |
| UnnamedSample_HQ_transcript/22226|m.7491 | UnnamedSample_HQ_transcript/22226 | Coverage 0.831 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF00387 | Phosphatidylinositol-specific phospholipase C, Y domain | 592 | 705 | 1.5E-39 | T | 22-09-2020 | IPR001711 | Phospholipase C, phosphatidylinositol-specific, Y domain |
| UnnamedSample_HQ_transcript/22226|m.7491 | UnnamedSample_HQ_transcript/22226 | Coverage 0.831 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF17787 | PH domain | 12 | 139 | 1.8E-44 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/18249|m.6379 | UnnamedSample_HQ_transcript/18249 | Coverage 0.783 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF09279 | Phosphoinositide-specific phospholipase C, efhand-like | 212 | 308 | 6.1E-11 | T | 22-09-2020 | IPR015359 | Phosphoinositide-specific phospholipase C, EF-hand-like domain |
| UnnamedSample_HQ_transcript/18249|m.6379 | UnnamedSample_HQ_transcript/18249 | Coverage 0.783 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF00388 | Phosphatidylinositol-specific phospholipase C, X domain | 319 | 466 | 6.5E-60 | T | 22-09-2020 | IPR000909 | Phosphatidylinositol-specific phospholipase C, X domain |
| UnnamedSample_HQ_transcript/18249|m.6379 | UnnamedSample_HQ_transcript/18249 | Coverage 0.783 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF00387 | Phosphatidylinositol-specific phospholipase C, Y domain | 592 | 705 | 1.5E-39 | T | 22-09-2020 | IPR001711 | Phospholipase C, phosphatidylinositol-specific, Y domain |
| UnnamedSample_HQ_transcript/18249|m.6379 | UnnamedSample_HQ_transcript/18249 | Coverage 0.783 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF17787 | PH domain | 12 | 139 | 1.8E-44 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/25154|m.8255 | UnnamedSample_HQ_transcript/25154 | Coverage 0.863 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF09279 | Phosphoinositide-specific phospholipase C, efhand-like | 212 | 308 | 6.1E-11 | T | 22-09-2020 | IPR015359 | Phosphoinositide-specific phospholipase C, EF-hand-like domain |
| UnnamedSample_HQ_transcript/25154|m.8255 | UnnamedSample_HQ_transcript/25154 | Coverage 0.863 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF00388 | Phosphatidylinositol-specific phospholipase C, X domain | 319 | 466 | 6.5E-60 | T | 22-09-2020 | IPR000909 | Phosphatidylinositol-specific phospholipase C, X domain |
| UnnamedSample_HQ_transcript/25154|m.8255 | UnnamedSample_HQ_transcript/25154 | Coverage 0.863 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF00387 | Phosphatidylinositol-specific phospholipase C, Y domain | 592 | 705 | 1.5E-39 | T | 22-09-2020 | IPR001711 | Phospholipase C, phosphatidylinositol-specific, Y domain |
| UnnamedSample_HQ_transcript/25154|m.8255 | UnnamedSample_HQ_transcript/25154 | Coverage 0.863 too low. | 06adb8040f46bc9da05fb36765450efc | 985 | Pfam | PF17787 | PH domain | 12 | 139 | 1.8E-44 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/13811|m.5053 | UnnamedSample_HQ_transcript/13811 | Identity 0.704 too low. | ffd4e284ac06be95a0b8c727e7c7c661 | 584 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 34 | 187 | 1.3E-15 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/13811|m.5053 | UnnamedSample_HQ_transcript/13811 | Identity 0.704 too low. | ffd4e284ac06be95a0b8c727e7c7c661 | 584 | Pfam | PF00183 | Hsp90 protein | 190 | 579 | 3.6E-173 | T | 22-09-2020 | IPR001404 | Heat shock protein Hsp90 family |
| UnnamedSample_HQ_transcript/89699|m.21192 | UnnamedSample_HQ_transcript/89699 | Coverage 0.576 too low. | 8a6456bf6eb9699be28cd59029a83835 | 295 | Pfam | PF15749 | MRN-interacting protein | 54 | 169 | 7.2E-28 | T | 22-09-2020 | IPR032739 | MRN complex-interacting protein |
| UnnamedSample_HQ_transcript/53012|m.14647 | UnnamedSample_HQ_transcript/53012 | Coverage 0.989 too low. | 107a19aba2379cac1f0ed4212f7b83dd | 580 | Pfam | PF01602 | Adaptin N terminal region | 1 | 304 | 7.7E-60 | T | 22-09-2020 | IPR002553 | Clathrin/coatomer adaptor, adaptin-like, N-terminal |
| UnnamedSample_HQ_transcript/53012|m.14647 | UnnamedSample_HQ_transcript/53012 | Coverage 0.989 too low. | 107a19aba2379cac1f0ed4212f7b83dd | 580 | Pfam | PF02883 | Adaptin C-terminal domain | 466 | 575 | 1.8E-30 | T | 22-09-2020 | IPR008152 | Clathrin adaptor, alpha/beta/gamma-adaptin, appendage, Ig-like subdomain |
| UnnamedSample_HQ_transcript/55754|m.15187 | UnnamedSample_HQ_transcript/55754 | Coverage 0.753 too low. | 934c66fe7617b9376855839f71a4321d | 624 | Pfam | PF00271 | Helicase conserved C-terminal domain | 320 | 432 | 3.3E-20 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/55754|m.15187 | UnnamedSample_HQ_transcript/55754 | Coverage 0.753 too low. | 934c66fe7617b9376855839f71a4321d | 624 | Pfam | PF00176 | SNF2 family N-terminal domain | 25 | 293 | 1.2E-62 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/21405|m.7253 | UnnamedSample_HQ_transcript/21405 | Coverage 0.549 too low. | e61ee0f50fb790ad2815446f38a80ab7 | 484 | Pfam | PF00571 | CBS domain | 373 | 420 | 7.7E-10 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/21405|m.7253 | UnnamedSample_HQ_transcript/21405 | Coverage 0.549 too low. | e61ee0f50fb790ad2815446f38a80ab7 | 484 | Pfam | PF00571 | CBS domain | 227 | 273 | 9.2E-6 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/21405|m.7253 | UnnamedSample_HQ_transcript/21405 | Coverage 0.549 too low. | e61ee0f50fb790ad2815446f38a80ab7 | 484 | Pfam | PF00571 | CBS domain | 300 | 346 | 4.5E-7 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/58341|m.15720 | UnnamedSample_HQ_transcript/58341 | Identity 0.741 too low. | 24729e5f13e1cdf6ebe77638e645e264 | 413 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 1 | 184 | 2.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/66746|m.17359 | UnnamedSample_HQ_transcript/66746 | Identity 0.716 too low. | 24729e5f13e1cdf6ebe77638e645e264 | 413 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 1 | 184 | 2.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/69325|m.17815 | UnnamedSample_HQ_transcript/69325 | Coverage 0.807 too low. | e7554152b9ec2b1181e9d059012cf89a | 538 | Pfam | PF00135 | Carboxylesterase family | 5 | 528 | 2.8E-103 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/54453|m.14928 | UnnamedSample_HQ_transcript/54453 | Coverage 0.981 too low. | d6817af28139767a4902fa297e4a1e88 | 517 | Pfam | PF04925 | SHQ1 protein | 262 | 430 | 1.8E-51 | T | 22-09-2020 | IPR007009 | Shq1 protein domain |
| UnnamedSample_HQ_transcript/22898|m.7664 | UnnamedSample_HQ_transcript/22898 | Coverage 0.913 too low. | d2279f11930102f4c13e32b6c867157f | 827 | Pfam | PF11635 | Mediator complex subunit 16 | 126 | 810 | 2.3E-48 | T | 22-09-2020 | IPR021665 | Mediator complex, subunit Med16 |
| UnnamedSample_HQ_transcript/111287|m.23997 | UnnamedSample_HQ_transcript/111287 | Unmapped. | b5a7b16d1c65ca3c9c47a4efdedc5a12 | 251 | Pfam | PF00240 | Ubiquitin family | 155 | 226 | 6.8E-34 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/111287|m.23997 | UnnamedSample_HQ_transcript/111287 | Unmapped. | b5a7b16d1c65ca3c9c47a4efdedc5a12 | 251 | Pfam | PF00240 | Ubiquitin family | 3 | 74 | 6.8E-34 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/111287|m.23997 | UnnamedSample_HQ_transcript/111287 | Unmapped. | b5a7b16d1c65ca3c9c47a4efdedc5a12 | 251 | Pfam | PF00240 | Ubiquitin family | 79 | 150 | 6.8E-34 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/19216|m.6640 | UnnamedSample_HQ_transcript/19216 | Coverage 0.847 too low. | bae547b9fc96ab22694ea8b677675ab5 | 755 | Pfam | PF00096 | Zinc finger, C2H2 type | 613 | 635 | 1.7E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/23444|m.7792 | UnnamedSample_HQ_transcript/23444 | Coverage 0.839 too low. | bae547b9fc96ab22694ea8b677675ab5 | 755 | Pfam | PF00096 | Zinc finger, C2H2 type | 613 | 635 | 1.7E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/27149|m.8757 | UnnamedSample_HQ_transcript/27149 | Coverage 0.831 too low. | bae547b9fc96ab22694ea8b677675ab5 | 755 | Pfam | PF00096 | Zinc finger, C2H2 type | 613 | 635 | 1.7E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/42721|m.12422 | UnnamedSample_HQ_transcript/42721 | Coverage 0.948 too low. | d62be4f76f5ddd67b3397e5560d967a6 | 651 | Pfam | PF00012 | Hsp70 protein | 6 | 609 | 3.5E-259 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/11099|m.4187 | UnnamedSample_HQ_transcript/11099 | Identity 0.706 too low. | 9029941ec216ec3ec17766a0501865cf | 1095 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 544 | 1092 | 1.8E-191 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
| UnnamedSample_HQ_transcript/11099|m.4187 | UnnamedSample_HQ_transcript/11099 | Identity 0.706 too low. | 9029941ec216ec3ec17766a0501865cf | 1095 | Pfam | PF01833 | IPT/TIG domain | 142 | 222 | 1.9E-8 | T | 22-09-2020 | IPR002909 | IPT domain |
| UnnamedSample_HQ_transcript/8935|m.3493 | UnnamedSample_HQ_transcript/8935 | Coverage 0.080 too low. | f2005f8edf72d9440fa49e0941d8bbff | 152 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 1 | 147 | 3.8E-48 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/24263|m.8012 | UnnamedSample_HQ_transcript/24263 | Coverage 0.989 too low. | 221b5b98c65f9dba51cfa91678b8c0bd | 640 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 240 | 297 | 8.5E-23 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/24263|m.8012 | UnnamedSample_HQ_transcript/24263 | Coverage 0.989 too low. | 221b5b98c65f9dba51cfa91678b8c0bd | 640 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 344 | 639 | 9.9E-59 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/58630|m.15779 | UnnamedSample_HQ_transcript/58630 | Coverage 0.553 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/58630|m.15779 | UnnamedSample_HQ_transcript/58630 | Coverage 0.553 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/44024|m.12721 | UnnamedSample_HQ_transcript/44024 | Identity 0.652 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/44024|m.12721 | UnnamedSample_HQ_transcript/44024 | Identity 0.652 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/38438|m.11490 | UnnamedSample_HQ_transcript/38438 | Identity 0.675 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/38438|m.11490 | UnnamedSample_HQ_transcript/38438 | Identity 0.675 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/52119|m.14478 | UnnamedSample_HQ_transcript/52119 | Identity 0.614 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/52119|m.14478 | UnnamedSample_HQ_transcript/52119 | Identity 0.614 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/47276|m.13423 | UnnamedSample_HQ_transcript/47276 | Identity 0.679 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/47276|m.13423 | UnnamedSample_HQ_transcript/47276 | Identity 0.679 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/53414|m.14721 | UnnamedSample_HQ_transcript/53414 | Identity 0.614 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/53414|m.14721 | UnnamedSample_HQ_transcript/53414 | Identity 0.614 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/57202|m.15486 | UnnamedSample_HQ_transcript/57202 | Identity 0.583 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/57202|m.15486 | UnnamedSample_HQ_transcript/57202 | Identity 0.583 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/57722|m.15600 | UnnamedSample_HQ_transcript/57722 | Coverage 0.529 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/57722|m.15600 | UnnamedSample_HQ_transcript/57722 | Coverage 0.529 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/48713|m.13744 | UnnamedSample_HQ_transcript/48713 | Identity 0.631 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/48713|m.13744 | UnnamedSample_HQ_transcript/48713 | Identity 0.631 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/37425|m.11256 | UnnamedSample_HQ_transcript/37425 | Identity 0.679 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/37425|m.11256 | UnnamedSample_HQ_transcript/37425 | Identity 0.679 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/40336|m.11920 | UnnamedSample_HQ_transcript/40336 | Identity 0.667 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/40336|m.11920 | UnnamedSample_HQ_transcript/40336 | Identity 0.667 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/63320|m.16694 | UnnamedSample_HQ_transcript/63320 | Identity 0.618 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/63320|m.16694 | UnnamedSample_HQ_transcript/63320 | Identity 0.618 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/57610|m.15568 | UnnamedSample_HQ_transcript/57610 | Identity 0.635 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/57610|m.15568 | UnnamedSample_HQ_transcript/57610 | Identity 0.635 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/65094|m.17048 | UnnamedSample_HQ_transcript/65094 | Identity 0.545 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/65094|m.17048 | UnnamedSample_HQ_transcript/65094 | Identity 0.545 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/68537|m.17673 | UnnamedSample_HQ_transcript/68537 | Coverage 0.510 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/68537|m.17673 | UnnamedSample_HQ_transcript/68537 | Coverage 0.510 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/62763|m.16589 | UnnamedSample_HQ_transcript/62763 | Identity 0.557 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/62763|m.16589 | UnnamedSample_HQ_transcript/62763 | Identity 0.557 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/50898|m.14224 | UnnamedSample_HQ_transcript/50898 | Identity 0.621 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/50898|m.14224 | UnnamedSample_HQ_transcript/50898 | Identity 0.621 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/55098|m.15059 | UnnamedSample_HQ_transcript/55098 | Coverage 0.529 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/55098|m.15059 | UnnamedSample_HQ_transcript/55098 | Coverage 0.529 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/56923|m.15425 | UnnamedSample_HQ_transcript/56923 | Identity 0.598 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/56923|m.15425 | UnnamedSample_HQ_transcript/56923 | Identity 0.598 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/57954|m.15639 | UnnamedSample_HQ_transcript/57954 | Identity 0.588 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/57954|m.15639 | UnnamedSample_HQ_transcript/57954 | Identity 0.588 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/41518|m.12162 | UnnamedSample_HQ_transcript/41518 | Identity 0.660 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/41518|m.12162 | UnnamedSample_HQ_transcript/41518 | Identity 0.660 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/43915|m.12696 | UnnamedSample_HQ_transcript/43915 | Identity 0.642 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/43915|m.12696 | UnnamedSample_HQ_transcript/43915 | Identity 0.642 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/49245|m.13864 | UnnamedSample_HQ_transcript/49245 | Identity 0.621 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/49245|m.13864 | UnnamedSample_HQ_transcript/49245 | Identity 0.621 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/52847|m.14614 | UnnamedSample_HQ_transcript/52847 | Identity 0.614 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF13639 | Ring finger domain | 238 | 281 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/52847|m.14614 | UnnamedSample_HQ_transcript/52847 | Identity 0.614 too low. | c1ceede7885c99530ee1f425ccc7fa9b | 430 | Pfam | PF02225 | PA domain | 65 | 153 | 1.4E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/86969|m.20799 | UnnamedSample_HQ_transcript/86969 | Coverage 0.905 too low. | 4d29503ca41dc799f25024ba0fa9d04e | 216 | Pfam | PF02188 | GoLoco motif | 111 | 132 | 5.6E-9 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/86969|m.20799 | UnnamedSample_HQ_transcript/86969 | Coverage 0.905 too low. | 4d29503ca41dc799f25024ba0fa9d04e | 216 | Pfam | PF02188 | GoLoco motif | 62 | 83 | 6.5E-12 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/86969|m.20799 | UnnamedSample_HQ_transcript/86969 | Coverage 0.905 too low. | 4d29503ca41dc799f25024ba0fa9d04e | 216 | Pfam | PF02188 | GoLoco motif | 193 | 212 | 2.8E-10 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/71010|m.18113 | UnnamedSample_HQ_transcript/71010 | Identity 0.890 too low. | 9cc3c2960b06a9d72fbe0c2e0eca6f1f | 147 | Pfam | PF07645 | Calcium-binding EGF domain | 89 | 123 | 3.4E-6 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/33949|m.10449 | UnnamedSample_HQ_transcript/33949 | Unmapped. | 7fe405c877be3fe96ddc564741e45cac | 736 | Pfam | PF00910 | RNA helicase | 379 | 487 | 2.0E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/74325|m.18710 | UnnamedSample_HQ_transcript/74325 | Coverage 0.682 too low. | babfd26aa6b5b14315b9d9cc7022baf5 | 287 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 41 | 98 | 1.1E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/45345|m.12991 | UnnamedSample_HQ_transcript/45345 | Coverage 0.393 too low. | 8eebc25be6c39e20d8f66dabba82c1ab | 634 | Pfam | PF00063 | Myosin head (motor domain) | 441 | 576 | 7.3E-33 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/45345|m.12991 | UnnamedSample_HQ_transcript/45345 | Coverage 0.393 too low. | 8eebc25be6c39e20d8f66dabba82c1ab | 634 | Pfam | PF00063 | Myosin head (motor domain) | 3 | 276 | 2.5E-72 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/17055|m.6023 | UnnamedSample_HQ_transcript/17055 | Coverage 0.791 too low. | b58056ee6a617f7efa222b47137a07ab | 855 | Pfam | PF00780 | CNH domain | 548 | 825 | 5.8E-62 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/50637|m.14159 | UnnamedSample_HQ_transcript/50637 | Coverage 0.967 too low. | c030ef5b8595b23d2b0a926fd8b88fc8 | 335 | Pfam | PF00916 | Sulfate permease family | 1 | 130 | 3.4E-23 | T | 22-09-2020 | IPR011547 | SLC26A/SulP transporter domain |
| UnnamedSample_HQ_transcript/2149|m.1112 | UnnamedSample_HQ_transcript/2149 | Coverage 0.293 too low. | 3100258886760eaaa98f6bc936d1e1b2 | 1306 | Pfam | PF00439 | Bromodomain | 353 | 433 | 5.6E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/10687|m.4047 | UnnamedSample_HQ_transcript/10687 | Coverage 0.976 too low. | 7af298839f5d797f9be84e4ddda00cac | 923 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 352 | 664 | 2.0E-16 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/10687|m.4047 | UnnamedSample_HQ_transcript/10687 | Coverage 0.976 too low. | 7af298839f5d797f9be84e4ddda00cac | 923 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 39 | 104 | 1.0E-13 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/10687|m.4047 | UnnamedSample_HQ_transcript/10687 | Coverage 0.976 too low. | 7af298839f5d797f9be84e4ddda00cac | 923 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 735 | 906 | 4.0E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/10687|m.4047 | UnnamedSample_HQ_transcript/10687 | Coverage 0.976 too low. | 7af298839f5d797f9be84e4ddda00cac | 923 | Pfam | PF00122 | E1-E2 ATPase | 143 | 336 | 1.9E-51 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/14460|m.5254 | UnnamedSample_HQ_transcript/14460 | Coverage 0.924 too low. | a4e4d4a3b1a53c6f05056f327c9d35a5 | 963 | Pfam | PF00364 | Biotin-requiring enzyme | 895 | 962 | 1.7E-18 | T | 22-09-2020 | IPR000089 | Biotin/lipoyl attachment |
| UnnamedSample_HQ_transcript/14460|m.5254 | UnnamedSample_HQ_transcript/14460 | Coverage 0.924 too low. | a4e4d4a3b1a53c6f05056f327c9d35a5 | 963 | Pfam | PF02785 | Biotin carboxylase C-terminal domain | 143 | 251 | 2.2E-31 | T | 22-09-2020 | IPR005482 | Biotin carboxylase, C-terminal |
| UnnamedSample_HQ_transcript/14460|m.5254 | UnnamedSample_HQ_transcript/14460 | Coverage 0.924 too low. | a4e4d4a3b1a53c6f05056f327c9d35a5 | 963 | Pfam | PF02786 | Carbamoyl-phosphate synthase L chain, ATP binding domain | 1 | 127 | 2.5E-50 | T | 22-09-2020 | IPR005479 | Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain |
| UnnamedSample_HQ_transcript/14460|m.5254 | UnnamedSample_HQ_transcript/14460 | Coverage 0.924 too low. | a4e4d4a3b1a53c6f05056f327c9d35a5 | 963 | Pfam | PF02436 | Conserved carboxylase domain | 646 | 844 | 4.9E-70 | T | 22-09-2020 | IPR003379 | Carboxylase, conserved domain |
| UnnamedSample_HQ_transcript/14460|m.5254 | UnnamedSample_HQ_transcript/14460 | Coverage 0.924 too low. | a4e4d4a3b1a53c6f05056f327c9d35a5 | 963 | Pfam | PF00682 | HMGL-like | 350 | 620 | 6.9E-28 | T | 22-09-2020 | IPR000891 | Pyruvate carboxyltransferase |
| UnnamedSample_HQ_transcript/69898|m.17912 | UnnamedSample_HQ_transcript/69898 | Coverage 0.844 too low. | 972949e140af8829abd3df2543e19725 | 321 | Pfam | PF00441 | Acyl-CoA dehydrogenase, C-terminal domain | 1 | 140 | 2.4E-34 | T | 22-09-2020 | IPR009075 | Acyl-CoA dehydrogenase/oxidase C-terminal |
| UnnamedSample_HQ_transcript/20351|m.6962 | UnnamedSample_HQ_transcript/20351 | Unmapped. | a85280ec53f870049432a3d02c10a761 | 842 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 600 | 839 | 6.8E-28 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/106967|m.23454 | UnnamedSample_HQ_transcript/106967 | Coverage 0.986 too low. | fa98dcc0c843626720a32cdf610c5bf6 | 300 | Pfam | PF05485 | THAP domain | 5 | 91 | 9.3E-15 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/106967|m.23454 | UnnamedSample_HQ_transcript/106967 | Coverage 0.986 too low. | fa98dcc0c843626720a32cdf610c5bf6 | 300 | Pfam | PF07776 | Zinc-finger associated domain (zf-AD) | 215 | 287 | 3.1E-12 | T | 22-09-2020 | IPR012934 | Zinc finger, AD-type |
| UnnamedSample_HQ_transcript/48795|m.13759 | UnnamedSample_HQ_transcript/48795 | Coverage 0.868 too low. | b30000b2a7cbc947857d45ecb9987942 | 631 | Pfam | PF01204 | Trehalase | 88 | 613 | 9.1E-123 | T | 22-09-2020 | IPR001661 | Glycoside hydrolase, family 37 |
| UnnamedSample_HQ_transcript/86691|m.20756 | UnnamedSample_HQ_transcript/86691 | Coverage 0.899 too low. | 607c6cdc04a9cea5c5c537e19b474099 | 137 | Pfam | PF00436 | Single-strand binding protein family | 34 | 135 | 3.4E-24 | T | 22-09-2020 | IPR000424 | Primosome PriB/single-strand DNA-binding |
| UnnamedSample_HQ_transcript/92668|m.21618 | UnnamedSample_HQ_transcript/92668 | Coverage 0.949 too low. | 1f03970d2e14ddb544d11f047a984d65 | 371 | Pfam | PF07690 | Major Facilitator Superfamily | 3 | 290 | 3.4E-31 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/87182|m.20819 | UnnamedSample_HQ_transcript/87182 | Coverage 0.086 too low. | 912014d2f05f2a3f703e30d3b2eba6a6 | 194 | Pfam | PF01393 | Chromo shadow domain | 137 | 187 | 3.6E-17 | T | 22-09-2020 | IPR008251 | Chromo shadow domain |
| UnnamedSample_HQ_transcript/87182|m.20819 | UnnamedSample_HQ_transcript/87182 | Coverage 0.086 too low. | 912014d2f05f2a3f703e30d3b2eba6a6 | 194 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 13 | 63 | 4.7E-16 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/3485|m.1612 | UnnamedSample_HQ_transcript/3485 | Coverage 0.078 too low. | e81041abe9230c7bbdfe1da4c969f041 | 189 | Pfam | PF12884 | Transducer of regulated CREB activity, N terminus | 5 | 48 | 6.3E-19 | T | 22-09-2020 | IPR024783 | Transducer of regulated CREB activity, N-terminal |
| UnnamedSample_HQ_transcript/1772|m.967 | UnnamedSample_HQ_transcript/1772 | Coverage 0.830 too low. | 2bfb694c5c5ac774d6856f372cc977cf | 430 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 62 | 333 | 6.4E-69 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/4408|m.1961 | UnnamedSample_HQ_transcript/4408 | Identity 0.927 too low. | 42dc67198ce7273b62fa5f34449d4feb | 1270 | Pfam | PF00595 | PDZ domain | 1036 | 1116 | 5.2E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/4408|m.1961 | UnnamedSample_HQ_transcript/4408 | Identity 0.927 too low. | 42dc67198ce7273b62fa5f34449d4feb | 1270 | Pfam | PF00595 | PDZ domain | 1182 | 1263 | 1.6E-14 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/5058|m.2216 | UnnamedSample_HQ_transcript/5058 | Identity 0.926 too low. | 42dc67198ce7273b62fa5f34449d4feb | 1270 | Pfam | PF00595 | PDZ domain | 1036 | 1116 | 5.2E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/5058|m.2216 | UnnamedSample_HQ_transcript/5058 | Identity 0.926 too low. | 42dc67198ce7273b62fa5f34449d4feb | 1270 | Pfam | PF00595 | PDZ domain | 1182 | 1263 | 1.6E-14 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/6842|m.2809 | UnnamedSample_HQ_transcript/6842 | Coverage 0.271 too low. | a650836062024fa6a4d797a80de147c0 | 1410 | Pfam | PF01302 | CAP-Gly domain | 140 | 204 | 5.0E-19 | T | 22-09-2020 | IPR000938 | CAP Gly-rich domain |
| UnnamedSample_HQ_transcript/39647|m.11773 | UnnamedSample_HQ_transcript/39647 | Coverage 0.845 too low. | cdcad46431c22a53ce5cf31130e48376 | 282 | Pfam | PF00002 | 7 transmembrane receptor (Secretin family) | 36 | 229 | 2.7E-17 | T | 22-09-2020 | IPR000832 | GPCR, family 2, secretin-like |
| UnnamedSample_HQ_transcript/42561|m.12386 | UnnamedSample_HQ_transcript/42561 | Coverage 0.881 too low. | cdcad46431c22a53ce5cf31130e48376 | 282 | Pfam | PF00002 | 7 transmembrane receptor (Secretin family) | 36 | 229 | 2.7E-17 | T | 22-09-2020 | IPR000832 | GPCR, family 2, secretin-like |
| UnnamedSample_HQ_transcript/14033|m.5117 | UnnamedSample_HQ_transcript/14033 | Coverage 0.681 too low. | cdcad46431c22a53ce5cf31130e48376 | 282 | Pfam | PF00002 | 7 transmembrane receptor (Secretin family) | 36 | 229 | 2.7E-17 | T | 22-09-2020 | IPR000832 | GPCR, family 2, secretin-like |
| UnnamedSample_HQ_transcript/93133|m.21685 | UnnamedSample_HQ_transcript/93133 | Coverage 0.767 too low. | 441fad705bf239effe4a30110b946c44 | 267 | Pfam | PF00876 | Innexin | 26 | 255 | 4.2E-62 | T | 22-09-2020 | IPR000990 | Innexin |
| UnnamedSample_HQ_transcript/53375|m.14715 | UnnamedSample_HQ_transcript/53375 | Coverage 0.057 too low. | 8bcb9516798e21c1425aa3e7f6bf60de | 168 | Pfam | PF13499 | EF-hand domain pair | 4 | 52 | 3.9E-9 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/80236|m.19753 | UnnamedSample_HQ_transcript/80236 | Coverage 0.692 too low. | 9920bf3c9667cd5c8951db97e24dd387 | 302 | Pfam | PF00013 | KH domain | 90 | 151 | 2.0E-14 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/17523|m.6166 | UnnamedSample_HQ_transcript/17523 | Coverage 0.987 too low. | 26d6b07153dab50371de2e5ab2492a39 | 986 | Pfam | PF01388 | ARID/BRIGHT DNA binding domain | 385 | 470 | 7.0E-18 | T | 22-09-2020 | IPR001606 | ARID DNA-binding domain |
| UnnamedSample_HQ_transcript/17671|m.6212 | UnnamedSample_HQ_transcript/17671 | Coverage 0.952 too low. | 5ec27eb158c306b04f8233ba3cd9e6ea | 437 | Pfam | PF01061 | ABC-2 type transporter | 177 | 386 | 9.5E-48 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/17671|m.6212 | UnnamedSample_HQ_transcript/17671 | Coverage 0.952 too low. | 5ec27eb158c306b04f8233ba3cd9e6ea | 437 | Pfam | PF19055 | ABC-2 type transporter | 53 | 120 | 1.9E-10 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/34313|m.10552 | UnnamedSample_HQ_transcript/34313 | Coverage 0.722 too low. | d674fe9407c94f24620cd6592932e03e | 581 | Pfam | PF00501 | AMP-binding enzyme | 109 | 570 | 2.6E-92 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/11031|m.4158 | UnnamedSample_HQ_transcript/11031 | Coverage 0.898 too low. | 4d45fbca6bedb66e77751bfda47d5980 | 1052 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 859 | 1022 | 1.2E-62 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/10094|m.3864 | UnnamedSample_HQ_transcript/10094 | Coverage 0.903 too low. | 4d45fbca6bedb66e77751bfda47d5980 | 1052 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 859 | 1022 | 1.2E-62 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/12628|m.4704 | UnnamedSample_HQ_transcript/12628 | Coverage 0.894 too low. | 4d45fbca6bedb66e77751bfda47d5980 | 1052 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 859 | 1022 | 1.2E-62 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/12938|m.4801 | UnnamedSample_HQ_transcript/12938 | Unmapped. | b43901a5563f5d333fef6fa85000bf45 | 1214 | Pfam | PF14318 | Mononegavirales mRNA-capping region V | 1028 | 1213 | 4.6E-36 | T | 22-09-2020 | IPR026890 | Mononegavirales mRNA-capping domain V |
| UnnamedSample_HQ_transcript/12938|m.4801 | UnnamedSample_HQ_transcript/12938 | Unmapped. | b43901a5563f5d333fef6fa85000bf45 | 1214 | Pfam | PF00946 | Mononegavirales RNA dependent RNA polymerase | 64 | 1008 | 6.3E-165 | T | 22-09-2020 | IPR014023 | Mononegavirales RNA-directed RNA polymerase catalytic domain |
| UnnamedSample_HQ_transcript/24543|m.8082 | UnnamedSample_HQ_transcript/24543 | Coverage 0.636 too low. | e1fa4d8c6bbabb18e80c233033b0477f | 776 | Pfam | PF02190 | ATP-dependent protease La (LON) substrate-binding domain | 3 | 193 | 1.8E-15 | T | 22-09-2020 | IPR003111 | Lon, substrate-binding domain |
| UnnamedSample_HQ_transcript/24543|m.8082 | UnnamedSample_HQ_transcript/24543 | Coverage 0.636 too low. | e1fa4d8c6bbabb18e80c233033b0477f | 776 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 344 | 480 | 6.8E-24 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/24543|m.8082 | UnnamedSample_HQ_transcript/24543 | Coverage 0.636 too low. | e1fa4d8c6bbabb18e80c233033b0477f | 776 | Pfam | PF05362 | Lon protease (S16) C-terminal proteolytic domain | 562 | 769 | 6.1E-73 | T | 22-09-2020 | IPR008269 | Peptidase S16, Lon proteolytic domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
